Gaprin Market Size, Share, Growth, and Global Industry Growth by Type (Food Grape Gaprin, Feed Grade Gaprin), By Application (Food & Beverages, Animal Feed, and Other), Covid-19 Impact, Latest Trends, Segmentation, Driving Factors, Restraining Factors, Key Industry Players, Regional Insights, and Forecast From 2024 To 2031

Updated On: 01 April 2024

GAPRIN MARKET REPORT OVERVIEW

"The global gaprin market size was USD 363.2 million in 2022 and is projected to touch USD 9669.21 million by 2031, exhibiting a CAGR of 44.0% during the forecast period."

• 
• Request a Free sample to learn more about this report

Gaprin is a full-fledged microbiological protein made of inactivated cells of non-pathogenic methanotrophic bacteria. It's designed to be the main functional component of complex feeds and protein-vitamin supplements (BVD). It allows for the production of full, balanced compound feeds that support the intense development of livestock, poultry, and fish farming. Gaprin includes 70-79 percent crude protein. Gaprin is a complete protein product with a high amount of B vitamins (particularly B12), amino acids, and microelements that fully meet the demands of animals of various groups and ages, according to its composition.

The growing population and awareness of the benefits of alternative proteins, an increase in venture capital investments in alternative protein companies, the high nutritional value of edible insects, and the environmental sustainability benefits offered by alternative proteins, are driving gaprin market. In addition, the growing popularity of vegan diets presents huge growth prospects for alternative protein producers. However, the high cost of alternative proteins, and the widespread preference for animal-based goods, limit the market's expansion.

COVID-19 Impact: Restrictions on Various Industries to Obstruct Market Growth

The global COVID-19 pandemic has been unprecedented and staggering, with gaprin experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The spike in CAGR is attributable to the gaprin market growth and demand returning to pre-pandemic levels once the pandemic is over. 

The COVID-19 pandemic has wreaked havoc on the U.S., China, India, and a slew of other major European nations. The pandemic and statewide lockdowns have caused a drop in sales of these products, as most of these countries are major manufacturers of the instruments and consumables used for microbiological identification. This has had a negative impact on the market for microbial identification. However, in the coming years, the gaprin market is likely to revive.

LATEST TRENDS

"Environmental Footprint to Improve Market Progress"

One of the most important considerations is that it is significantly more sustainable than the majority of other protein sources now accessible. Microbial protein synthesis is substantially more environmentally friendly and consumes few natural resources when compared to other plant-based protein foods like soy and hemp. Therefore, it's an ideal solution for anyone looking to reduce their environmental footprint while also contributing to long-term sustainability.

GAPRIN MARKET SEGMENTATION

• 
• Request a Free sample to learn more about this report

• By Type

Based on type; the market is divided into Food Grape Gaprin, and Feed Grade Gaprin.

• By Application

Based on the application; the market is divided into Food & Beverages, Animal Feed, and Other.

DRIVING FACTORS

"Recent Developments to Strengthen Market Growth"

The increasing demand for microbial protein production services is being driven by an increase in the number of applications of microbial proteins, such as increasing enzymatic applications and their requirement in various industries, an increase in the production of biopharmaceuticals such as monoclonal antibodies, hepatitis B vaccine, and HPV vaccine. The market for pure and active proteins is constantly growing due to recent developments in proteomics and substantial expansion in the protein medicine sector. The gaprin market is also fueled by the growing number of CROs.

"Increasing adoption in Various Applications to Drive Product Demand"

Protein components are increasingly being used in important applications such as food and drinks, as the desire for increased functionality grows. During the forecast period, the ability of manufacturers to design and develop customized isolates, concentrates, and other forms of protein components for various applications is expected to fuel gaprin market expansion. Emulsification, gelation/viscosity, water-binding/hydration, foaming, aeration, and other functional qualities of protein components derived from animals and plants are well-known. These functions and the nutritional features of proteins, provide a significant benefit to end-user industries and are thus a major market driver. They are largely employed in end-user sectors such as cosmetics and personal care for their conditioning and moisturizing characteristics in the hair and skin care industries.

RESTRAINING FACTORS

"Maintenance Cost to Hamper Market Growth"

Increasing regulatory pressure on CROs, exorbitant costs, and a shortage of competent personnel, infrastructure, and experience may all limit gaprin market growth. Many of these systems are required by pharmaceutical enterprises, resulting in a large increase in capital costs. Due to their limited resources, academic research laboratories are unable to purchase such systems. In addition, the total cost of ownership of these instruments rises as a result of maintenance fees and a variety of additional indirect charges.

GAPRIN MARKET REGIONAL INSIGHTS

• 
• Request a Free sample to learn more about this report

"Asia Pacific to Lead Market Due to Presence of Majority of Market Players "

Asia Pacific holds the largest part of the global gaprin market share due to presence of because of the formation of more biotechnological and pharmaceutical enterprises, the opening of additional contract research organizations, and low-cost manufacturing are expected to drive the market forward in the region. China and India together comprise a dominating part of the market, which is expected to grow at a reasonably rapid rate due to population growth and changes in food consumption patterns. These developing countries are projected to increase their production rates for the market due to the lucrative expansion in the animal feed and nutraceutical supplement sectors.

China and India together comprise a dominating part of the gaprin market, which is expected to grow at a reasonably rapid rate due to population growth and changes in food consumption patterns. These developing countries are projected to increase their production rates for the market due to the lucrative expansion in the animal feed and nutraceutical supplement sectors.

North America is expected to have a sizable market share in the global market. The people's standard of living and their health consciousness are the main drivers of the market in the region. Therefore, the major actors have the opportunity to upgrade a variety of low-value organic and inorganic foods to valuable nutritional foods.

Europe is expected to have substantial market growth. This is due to a large number of contract research businesses and established networks of universities and research institutes in the region, European countries face intense rivalry.

KEY INDUSTRY PLAYERS

"Market Players to Boost Market Growth"

The report delivers information about the list of market players and their operations in the industry. The information is collected and reported with proper research, technological developments, acquisitions, mergers, expanding production lines, and partnerships. Other aspects examined for this market include companies producing and introducing new products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

List of Market Players Profiled

• Unibio
• Calysta
• Prtotelux
• Metanica
• Giprobioayntez

Industry Development

In 2020, the Australian Government released Australia’s next national antimicrobial resistance strategy, following an endorsement by the Council of Australian Governments. Australia’s National Antimicrobial Resistance Strategy - 2020 and beyond sets a 20-year vision to protect the health of humans, animals, and the environment by minimizing the development and spread of AMR while continuing to have effective antimicrobials available.

REPORT COVERAGE

This research profiles a report with extensive studies that take into a description the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.